Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Need attention

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 23, 2021 8:11pm

219 Views

Post# 34259795

RE:Need attention

A patent update -- one of the patent applications that has been floating around for some time is an association with 'cannibinoid'. It has hit another rejection. Not sure if it will be abandoned at this point or if they will take another run at it. They have 90 days to respond.

Transaction History

Request for Continued Examination (RCE)

Date	Transaction Description
12-18-2021	Final Rejection
08-26-2021	Affidavit(s) (Rule 131 or 132) or Exhibit(s) Received
08-27-2021	Date Forwarded to Examiner
08-26-2021

16/365,148

METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF A CANNABINOID RECEPTOR AGONIST AND RADIATION THERAPY

T1081/20069